FR2587212B1 - Compositions pharmaceutiques vasculoprotectrices contenant un derive d'ubiquinone et au moins un autre compose a activite vasculoprotectrice - Google Patents

Compositions pharmaceutiques vasculoprotectrices contenant un derive d'ubiquinone et au moins un autre compose a activite vasculoprotectrice

Info

Publication number
FR2587212B1
FR2587212B1 FR868606270A FR8606270A FR2587212B1 FR 2587212 B1 FR2587212 B1 FR 2587212B1 FR 868606270 A FR868606270 A FR 868606270A FR 8606270 A FR8606270 A FR 8606270A FR 2587212 B1 FR2587212 B1 FR 2587212B1
Authority
FR
France
Prior art keywords
vasculoproctor
activity
compound
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR868606270A
Other languages
English (en)
French (fr)
Other versions
FR2587212A1 (fr
Inventor
Pierre-Noel Brasey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seuref AG
Original Assignee
Seuref AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref AG filed Critical Seuref AG
Publication of FR2587212A1 publication Critical patent/FR2587212A1/fr
Application granted granted Critical
Publication of FR2587212B1 publication Critical patent/FR2587212B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR868606270A 1985-04-30 1986-04-30 Compositions pharmaceutiques vasculoprotectrices contenant un derive d'ubiquinone et au moins un autre compose a activite vasculoprotectrice Expired - Fee Related FR2587212B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1826/85A CH662505A5 (it) 1985-04-30 1985-04-30 Composizioni farmaceutiche ad azione protettiva vascolare.

Publications (2)

Publication Number Publication Date
FR2587212A1 FR2587212A1 (fr) 1987-03-20
FR2587212B1 true FR2587212B1 (fr) 1992-05-29

Family

ID=4219499

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868606270A Expired - Fee Related FR2587212B1 (fr) 1985-04-30 1986-04-30 Compositions pharmaceutiques vasculoprotectrices contenant un derive d'ubiquinone et au moins un autre compose a activite vasculoprotectrice

Country Status (10)

Country Link
US (1) US4707360A (https=)
JP (1) JPS61280424A (https=)
KR (1) KR860007927A (https=)
AT (1) AT393793B (https=)
BE (1) BE904696A (https=)
CH (1) CH662505A5 (https=)
DE (1) DE3614278A1 (https=)
FR (1) FR2587212B1 (https=)
GB (2) GB8610147D0 (https=)
NL (1) NL8601105A (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
FR2645442A1 (fr) * 1989-04-07 1990-10-12 Gueyne Jean Produit therapeutique a base de compose organique du silicium et de polyamine polycarboxylee, particulierement utile pour le traitement de l'atherome
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
IE911403A1 (en) * 1990-04-26 1991-11-06 Cytrx Corp Compositions and method for topical treatment of damaged or¹diseased tissue
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
FR2692145B1 (fr) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger Nouvelle composition à usage topique contenant de la diosmine.
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
US5683678A (en) * 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
JP2001504514A (ja) * 1996-11-27 2001-04-03 ドング クック ファーマシューティカル シーオー．，エルティーディー． アシアト酸誘導体を有効成分とする痴呆及び認識障害治療剤
KR100530278B1 (ko) 1997-02-28 2006-04-06 동국제약 주식회사 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders
US6159494A (en) * 1997-12-03 2000-12-12 Widgerow; Alan D Treatment of post operative scars with a tape containing a gel from Bulbine frutescens
US6423742B1 (en) 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
US6562864B1 (en) 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
ATE287723T1 (de) * 1999-09-10 2005-02-15 Ceteris Holding B V Amsterdam Ein antioxydierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und chronischen degenerativen problemen und von bluthochdruck
DE60019314T2 (de) * 1999-09-10 2006-04-27 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen
WO2002069992A1 (en) * 2001-03-02 2002-09-12 Biopharmacopae Design International Inc. Plant extracts and compositions comprising extracellular protease inhibitors
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
DE20109044U1 (de) * 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US6981883B2 (en) * 2001-11-14 2006-01-03 Fci Americas Technology, Inc. Impedance control in electrical connectors
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
CH670763A5 (https=) * 1985-08-02 1989-07-14 Seuref Ag

Also Published As

Publication number Publication date
GB2174904A (en) 1986-11-19
CH662505A5 (it) 1987-10-15
GB8610147D0 (en) 1986-05-29
BE904696A (nl) 1986-08-18
NL8601105A (nl) 1986-11-17
DE3614278A1 (de) 1986-10-30
JPS61280424A (ja) 1986-12-11
KR860007927A (ko) 1986-11-10
FR2587212A1 (fr) 1987-03-20
AT393793B (de) 1991-12-10
ATA115186A (de) 1991-06-15
JPH0344048B2 (https=) 1991-07-04
GB8610588D0 (en) 1986-06-04
GB2174904B (en) 1989-07-05
US4707360A (en) 1987-11-17

Similar Documents

Publication Publication Date Title
FR2587212B1 (fr) Compositions pharmaceutiques vasculoprotectrices contenant un derive d'ubiquinone et au moins un autre compose a activite vasculoprotectrice
FR2590893B1 (fr) Composition pharmaceutique effervescente a activite analgesique
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
IT1197038B (it) Composizione farmaceutica ad attivita' analgesica
FR2601588B1 (fr) Compositions pharmaceutiques a activite systemique pour l'application topique
MA20715A1 (fr) Composition d'essence
IT1186717B (it) Benzoil-uree ad attivita' insetticida
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
NL193022B (nl) N-acyl-alfa-amino-alfa,omega-alkaandicarbonzuuramiden en farmaceutisch preparaat dat een dergelijke verbinding bevat.
FR2582306B1 (fr) Sels d'acides n-acyl-thiazolidine-4-carboxyliques et de 6-piperidino-2,4-diaminopyrimidine-3-oxyde et compositions a usage cosmetique-dermatologique les contenant
NL193191B (nl) 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.
IT1187756B (it) Isoindolinil-alchil-piperazine ad attivita' farmaceutica
FR2589358B1 (fr) Compositions pharmaceutiques a base de diltiazem et d'aspirine
DK374988D0 (da) Tertiaere 2,5-dialkyl-3-phenylpiperidin-derivater med opiat-antagonistisk aktivitet og farmaceutiske kompositioner indeholdende forbindelserne
IT1215277B (it) Derivato chinolin-lattaminico ad attivita' antibatterica ed inibitrice delle b-lattamasi.
IT1191651B (it) Composti acilamminoalcanoilici ad attivita' farmaceutica
IT1177986B (it) Sostanze farmaceutiche e profilattiche antiadesivi contenenti un derivato benzilamminico ad attivita' secretolitica
FR2584294B1 (fr) Compositions pharmaceutiques a visee cytotrophique
FR2614788B1 (fr) Composition pharmaceutique a activite antiseptique
IT8621999A0 (it) Derivati pirido-benzotiazinici adattivita' antibatterica ed a lunga durata di azione.
IT8503595A0 (it) Composizioni veterinarie a basedi agenti antimicrobici e loro impiego
IT1186772B (it) Composto ad attivita' pilostimolante
BE892911A (fr) Nitroimidazoles a activite trichomonacide, leur preparation et compositions pharmaceutiques en contenant
FR2586352B1 (fr) Compositions pharmaceutiques contenant une coenzyme du type ubiquinone, douees d'activite de protection cardiaque et metabolique sur le metabolisme energetique musculaire
FR2589175B1 (fr) Dos d'ane escamotable

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse